User profiles for Biswajit Dubashi

BISWAJIT DUBASHI

Professor
Verified email at jipmer.ac.in
Cited by 1394

Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia

P Ganesan, TG Sagar, B Dubashi… - American journal of …, 2011 - Wiley Online Library
There is limited data on the impact of treatment interruptions due to nonadherence in patients
with chronic phase chronic myeloid leukemia (CP‐CML) treated with Imatinib. We looked …

Clinicopathological analysis and outcome of primary mediastinal malignancies—a report of 91 cases from a single institute

B Dubashi, S Cyriac, SG Tenali - Annals of thoracic medicine, 2009 - journals.lww.com
BACKGROUND: Primary mediastinal malignancies are uncommon. They can originate from
any mediastinal organ or tissue but most commonly arise from thymic, neurogenic, lymphatic…

Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric …

…, L Goenka, B Dubashi… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Anorexia occurs in 30%-80% of patients with advanced malignancies, which
may be worsened with chemotherapy. This trial assessed the efficacy of olanzapine in …

Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer

Y Nisha, B Dubashi, Z Bobby, JP Sahoo, S Kayal… - Archives of …, 2023 - Springer
Purpose The burden and mechanisms of endocrine therapy-related bone loss have been
studied in detail. However, there is limited data regarding cytotoxic chemotherapy’s impact on …

Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?

S Kodidela, P Suresh Chandra, B Dubashi - European journal of clinical …, 2014 - Springer
Purpose The antifolate drug methotrexate (MTX) was introduced into clinical practice about
60 years ago and remains an important component of different acute lymphoblastic leukemia …

Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis

…, XL Zhao, N Takahashi, S Angelini, B Dubashi… - …, 2017 - Future Medicine
Aim: The present study aimed to conduct a series of meta-analyses to investigate the influence
of imatinib trough concentration (C 0 ), as well as ABCB1 and ABCG2 polymorphisms, on …

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

…, JS Antony, M Subramani, B Dubashi… - Frontiers in …, 2023 - frontiersin.org
Glioma is the most devastating high-grade tumor of the central nervous system, with dismal
prognosis. Existing treatment modality does not provide substantial benefit to patients and …

Clinical presentation and outcome of pediatric ovarian germ cell tumor: a study of 40 patients

D Biswajit, CN Patil, TG Sagar - Journal of Pediatric Hematology …, 2010 - journals.lww.com
Background Germ cell tumor is a rare malignancy accounting for 3% of all pediatric tumors.
They are highly curable malignancies. The aim of this study was to evaluate the clinical …

[HTML][HTML] Late effects of breast cancer treatment and outcome after corrective interventions

…, P Madasamy, DK Muniswamy, B Dubashi - Asian Pacific Journal …, 2019 - ncbi.nlm.nih.gov
Purpose: To study the late toxicities of treatment and its impact on Breast cancer survivors
among Indian patients. Materials and Methods: Our study recruited 152 curatively treated non …

Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia

M Ponraj, B Dubashi, BH Harish, S Kayal… - Supportive Care in …, 2018 - Springer
Purpose Beta lactams are standard empirical therapy for febrile neutropenia (FN). The aim
of this study was to evaluate the efficacy and safety of cefepime monotherapy compared with …